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Naude et al. avoid answering the essential 
question: Mistake or mischief?
To the Editor: It is common cause that the Naude/Stellenbosch 
University/University of Cape Town meta-analysis[1] played a decisive 
role in the multimillion rand prosecution of Prof. T Noakes by the 
Health Professions Council of South Africa (HPCSA), which has now 
been ongoing for more than 3 years. The complainant, Claire Julsing-
Strydom, referred to the importance of a meta-analysis generally 
and/or the Naude et al.[1] meta-analysis specifically on 12 separate 
occasions during her testimony. On 24 November 2015, under oath, 
she said of the Naude et al.[1] publication: ‘So before any media state-
ments could be made we had to get that information and all these 
associations were waiting on that. It is not like the way you are saying 
it, it is not like everybody joined together to now make a statement 
against Prof. Noakes. We were all waiting for the evidence to be pub-
lished.’ Another prosecution witness, Prof. H Vorster, referred to the 
Naude et al.[1] meta-analysis five times and quoted from it verbatim 
once. A third prosecution witness, Prof. A Dhansay, referenced the 
meta-analysis twice, using the term ‘Cochrane’ to ensure that it was 
afforded the appropriate esteem. Without the ‘correct conclusion’ 
from this meta-analysis, it is possible that the HPCSA trial against 
Noakes might never have happened. Therefore, the importance of 
the Naude et al.[1] meta-analysis extends far beyond any role purely 
as a neutral scientific publication.
Had we realised the disproportionate consideration given to this 
ostensibly innocuous publication in the HPCSA trial, we would 
have examined it sooner. When we did examine it, we found the 
part used to claim that ‘Banting had been debunked’ to be replete 
with errors. We first presented these errors at the HPCSA/Noakes 
hearing on 24 October 2016, and then in the SAMJ.[2] Other than a 
misplaced article in the Cape Times, including comments from the 
authors on 20 December 2016,[3] the Naude et al.[4] letter published 
in the March 2017 edition of the SAMJ is the first response to our 
allegations.
The authors cheaply suggest that we show a ‘lack of understanding’ 
of their protocol. We understand the Naude et al.[1] protocol only too 
well. Indeed, we appear to understand it rather better than do its 
authors: 
• We understand that the authors set isolcaloric as a criterion, which 
would mitigate the satiety advantage of low(er)-carbohydrate 
(CHO) diets.
• We understand that the authors selected studies with an average 
CHO intake of 35% (35% fat, 30% protein) to represent ‘low CHO’ 
diets, which is substantially different from the 5% CHO (<50 g/day), 
moderate-protein and high-fat diet that is used for the therapeutic 
management of obesity and type 2 diabetes mellitus. 
• We understand that they set an inclusion criterion of 25 - 35% fat in 
the so-called balanced diet. This criterion was reiterated in Tables 2 
and 3[1] and yet ignored by the authors, as they included two studies[5,6] 
that failed their own criterion. These errors remain unaddressed by 
the authors in any of their responses. 
• We understand that they set the key outcome measure as ‘total 
weight change’. They then used end weight, with no reference to start 
weight, in two studies,[7,8] which was in breach of their own protocol 
and absurd. These errors remain unaddressed by the authors.
In their response to the SAMJ, the authors have accepted only one 
of the numerous errors that we documented in their article – their 
admission that they included a duplicate study.[9] This alone is 
grounds for retraction of the article.[10] 
The authors have not addressed any of the other numerous errors, 
material or otherwise, which we documented.[2] 
They have not addressed their sub-grouping, which resulted in the 
protein intake in the diet groups of their so-called high-protein 
and high-fat studies averaging 31.5 - 32.5% and 28.4%, respectively, 
likely a biologically insignificant difference. We described this sub-
grouping as ‘not necessary, not justified and not robust’.
The authors have not addressed their patently false claim that they 
used 52-week weight loss data for Wycherley et al.,[11] when they used 
data from 12 weeks instead. Use of the 52-week data would have 
favoured the lower-CHO intervention. 
The authors have not addressed using the wrong comparator diet 
for Krauss et al.,[12] which unnecessarily introduced a second variable 
and was to the advantage of the so-called ‘balanced’ diet. 
The authors have not explained from where they extracted the 
weight loss data of 2.65 kg for both the diet and control groups for 
Krauss et al.[12] Those specific data could not be found in the original 
publication. Instead, the actual data reported by Krauss et al.[12] 
slightly favoured the lower-CHO diet intervention. The authors have 
not addressed reporting the weight loss as 7.95 kg in the control diet 
rather than the 7.9 kg actually reported by Farnsworth et al.[13]
Instead of addressing these errors in detail, point by point, the 
authors have informed us of new errors that we missed. They wrote: ‘We 
used data from intention-to-treat analyses (and only if not reported, we 
used data from per-protocol analyses).’ This was not declared in their 
original protocol. Intention-to-treat (ITT) is mentioned in only two 
places in their 30-page article. It first appears in Table 8, which is the 
table assessing risk of bias. It then re-appears on p. 14 in the ‘Results: 
Risk of bias’ section. This is where ITT should appear – it is a measure 
of attrition bias (incomplete outcome data). The authors reported: 
‘Seven trials had low risk of attrition bias, with four reporting no 
attrition and three performing intention-to-treat analysis.’[1] 
The authors appear now to be confessing that they used ITT 
numbers instead of completers for some studies and not for others. 
A re-examination of their meta-analysis (Fig. 3), confirms that in 
three cases the participant numbers used differ to those extracted in 
Table 5, which in turn differ from the numbers used in the original 
publications on five occasions. ITT numbers have been used for 
Frisch et al.,[14] Klemsdal et al.[15] and Sacks et al.,[5] notwithstanding 
that Sacks should not have been included from the outset, having 
failed the authors’ inclusion criteria. 
These three studies favoured the low(er)-CHO diet, although the 
weight loss was reported the wrong way round by the authors for 
Sacks et al.;[5] therefore, it did not appear this way. The Cochrane 
Handbook for Systematic Reviews of Interventions[16] states that ‘ITT 
analyses tend to bias the results towards no difference …’ (section 
16.2). This choice thus aided the authors’ conclusion that there is 
little or no difference between the diets. Frisch et al.[14] reported that 
‘Missing data were replaced with baseline data in the intention-to-
treat analysis’. Klemsdal et al.[15] used the last observation carried 
forward (LOCF) technique and Sacks et al.[5] imputed an estimated 
weight gain of 0.3 kg/month for their ITT approach. But Cochrane 
warned of ‘A common, but potentially dangerous, approach to 
dealing with missing outcome data is to impute outcomes and treat 
them as if they were real measurements … Such procedures can lead 
both to serious bias and to confidence intervals that are too narrow 
… LOCF procedures can also lead to serious bias.’ 
In addition to this newly announced ITT methodology, which 
was not set out in their original protocol, the authors added another 
potential deflection, with an unsolicited reference to ‘standard 
mean difference’, which neither of us used. We used mean weight 
loss and standard deviations (SDs), as the authors did (apart from 
the De Luis et al.[7,8]  studies, for which they used end weight). We 
converted standard error measurements to SDs where necessary, as 
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the authors did, and we noted that we concurred with the authors’ 
conversion on four occasions, but found them to have erred with this 
calculation on three other occasions. These errors remain unaddressed 
by the authors.
As regards the accusation of ‘common mistake’, the researchers 
will be well aware, as are we, that in meta-analysis significant means 
statistically significant. The size of the statistical significance is 
immaterial. What is significant, in the non-statistical use of the 
word, is that our repeat of the authors’ meta-analysis, using their 
methodology, but without the errors, produced a different result – a 
result that would not have given those keen to prosecute Prof. Noakes 
the ammunition they were ‘waiting for’.
It is understandable that the authors chose rather to raise new 
issues (ITT, standard mean difference and significance) and to ignore 
the numerous errors that we identified in our critique, presumably 
because they have no cogent answers. As a result, those material 
errors have remained unanswered since October 2016 and unless 
addressed, they render the article worthless, other than of retraction. 
Given that only one error has been addressed and accepted 
(the duplication), we may never receive an answer to our research 
question: was this mistake or mischief? We may also never know if 
Prof. Noakes would have suffered for years in the way he has, had this 
article not made competence or conspiratorial errors.
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